This week's Fierce Cell & Gene is brought to you by InvestPR.

Complimentary Whitepaper Download

Hi E, check out this Fierce Whitepaper we think you'll like:

Puerto Rico on Gene & Cell Therapy: An Unparalleled Proposal for Non-Dilutive Funding

Due to numerous tax credits and incentives for research and development, hosting world-class talent, and the availability of securing non-diluted financing, Puerto Rico is becoming a nesting place for emerging technology companies and clinical stage biotech and pharma companies. According to the Bureau of Labor Statistics, Puerto Rico led U.S. exports of pharmaceutical and medicine manufacturing in 2020, accounting for 19.3 percent of total U.S. exports.

In this whitepaper you will learn about:

• The value of non-dilutive funding for emerging companies
• Puerto Rico’s taxation policies that dramatically reduce costs and foster investment
• The stability and protections afforded to companies being located within a territory of the U.S.
• The growing community and culture of innovative business leaders, accelerators, and incubators.